For many men, a prostate cancer scare starts with one number. A PSA result comes back high, and ...

A large analysis suggests that a multivariable risk assessment tool, called Stockholm3, can detect substantially more ...

(HealthDay News) — Stockholm3, which combines prostate-specific antigen (PSA), plasma protein biomarkers, polygenic risk, and clinical factors offers greater clinical net benefit for detecting ...

A new UCL-led international trial will assess whether AI can perform as well as expert radiologists at detecting prostate cancer on MRI scans. Following the practice-changing UCL-led PROMIS and ...

Extraprostatic extension or seminal vesicle invasion detected on preoperative MRI were independently associated with biochemical recurrence and metastatic failure after radical prostatectomy even ...

Primary endpoint analysis at 1 year showed better maintenance of erectile function and pad-free continence with TULSA than with robotic radical prostatectomy. Peri-procedural metrics favored TULSA, ...

Please provide your email address to receive an email when new articles are posted on . Staging from prostate-specific membrane androgen PET/CT had a significant association with PFS. Whole pelvis ...

FDA approved Pylarify TruVu, a higher-radioactivity-concentration formulation of piflufolastat F 18 designed to increase batch size and distribution efficiency while maintaining the established ...

March 6 (Reuters) - The U.S. Food and Drug Administration on Friday approved a new formulation of Lantheus Holdings' (LNTH.O), opens new tab prostate cancer imaging agent, aimed at improving ‌scanning ...

Full-body MRIs are all the rage. Celebrities and influencers tout the benefits of such scans that could find asymptomatic aneurysms and cancers lurking in your body. Sometimes, they're life-saving.

A combined PSMA-PET/MRI scanner better detected clinically significant prostate cancer in men on active surveillance. The addition of piflufolastat F18 (18 F-DCFPyL) prostate-specific membrane antigen ...